Evaluation of Attenuation Correction Accuracy in Positron Emission Tomography-Magnetic Resonance Imaging (PET-MRI)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-12-14

Study Completion Date

2020-03-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research proposal is to establish a mechanism to develop tools that will allow the investigators to measure the impact of magnetic resonance (MR) acquisition correction sequences for attenuation correction on positron emission tomography (PET) quantitation accuracy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Positron Emission Tomography/Magnetic Resonance Imaging in Patients

NCT01557881

Colon Cancer Head and Neck Cancer Lung Cancer +5 more

TERMINATED NA

Enhancing SUV Accuracy of PET/MR for Clinical Trial Qualification

NCT03603925

Positron Emission Tomography-Magnetic Resonance (PET-MR)

COMPLETED

PET/CT Evaluation of Treatment Response in Breast Cancer

NCT01222416

Breast Cancer

TERMINATED NA

Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals

NCT03125629

Cancer Diagnosis Diagnostic Techniques and Procedures Diagnostic Imaging

COMPLETED PHASE2

PET/MRI Perfusion and CT Perfusion in Solid Tumors

NCT02314962

CT Perfusion and MRI Perfusion in Solid Tumors

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

PET/CT

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PET/MR

* Participants will be scanned on a PET-MRI scanner which is FDA-approved and will operate within FDA-approved guidelines.
* Participants will be asked to lie still within the scanner for up to 90 minutes

Positron Emission Tomography-Magnetic Resonance Imaging (PET-MRI)

Intervention Type DEVICE

FDA approved scanner

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Positron Emission Tomography-Magnetic Resonance Imaging (PET-MRI)

FDA approved scanner

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

PET/MR PET/MRI

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participant must be ≥ 18 years of age
* Participant can be a male or a non-pregnant female.
* Successful completion of MRI screening form
* Participant must have undergone a PET/CT examination with injection of a standard dose of 18F-fluorodeoxyglucose (FDG) or other PET tracer with a half-life greater than one hour either for clinical or research purposes within 3 hrs of the proposed PET-MRI examination.
* Participant will be fully informed and has personally signed and dated the written Informed Consent and Health Insurance Portability and Accountability Act (HIPAA) provisions

Exclusion Criteria

* Subjects for whom exposure to a strong magnetic field would be a health risk (e.g., subjects with cardiac pacemakers or non-MR compatible metallic implants)
* Women who are pregnant.
* Subjects who require sedation to participate will be excluded.
* Patient/participant has a medical condition which in the judgment of the investigator might make supine positioning for the duration of the scan unsafe, such as (but not limited to) congestive heart failure or significant pulmonary disease.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes